-
Cover image
-
Title page
-
Table of Contents
-
Copyright
-
Contributors
-
Forthcoming Issues
-
Preface
-
Etiology and Pathophysiology of Diabetes Mellitus in Dogs
-
Key points
-
Introduction
-
Classification and description
-
Underlying risk factors
-
Pathophysiology
-
Future perspectives on precision diabetes management
-
Summary
-
Clinics care points
-
Disclosures
-
Pathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats
-
Key points
-
Introduction
-
Diabetes mellitus in cats
-
Factors contributing to diabetes mellitus development in cats
-
Prediabetes in cats
-
Diabetic remission in cats
-
Glucose tolerance in diabetic remission
-
Disclosure
-
Supplementary data
-
Diabetes Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome in Companion Animals
-
Key points
-
Definitions
-
Demographics
-
Ketogenesis
-
Predisposition and pathogenesis of diabetes ketoacidosis and euglycemic diabetes ketoacidosis
-
Predisposition and pathogenesis of hyperosmolar hyperglycemic state
-
Predisposition and pathogenesis of hyperosmolar diabetes ketoacidosis
-
Clinical history of diabetes ketoacidosis in dogs and cats
-
Physical examination findings
-
Clinical diagnosis of diabetes ketoacidosis
-
Other diagnostic tests
-
Clinical management of diabetes ketoacidosis
-
Outcome of dogs and cats with diabetes ketoacidosis
-
Clinics care points
-
Disclosure
-
Glucose Counterregulation: Clinical Consequences of Impaired Sympathetic Responses in Diabetic Dogs and Cats
-
Key points
-
Introduction
-
Frequency of insulin-induced hypoglycemia in diabetic dogs and cats
-
Clinical signs of insulin-induced hypoglycemia in diabetic dogs and cats
-
Glucagon responses to hypoglycemia are largely mediated by activation of the autonomic nervous system
-
Impaired counterregulatory responses to hypoglycemia in diabetes mellitus
-
The “Somogyi effect”: time to let it go
-
Summary
-
Clinics care points
-
Disclosure
-
Diabetes Mellitus and the Kidneys
-
Key points
-
Introduction
-
Summary
-
Clinics care points
-
Declaration of Interests
-
Anesthetic Considerations in Dogs and Cats with Diabetes Mellitus
-
Key points
-
Introduction
-
Anesthetic considerations and management
-
Disclosure
-
Continuous Glucose Monitoring in Dogs and Cats: Application of New Technology to an Old Problem
-
Key points
-
Introduction
-
Continuous glucose monitoring systems
-
Flash Glucose Monitoring Systems
-
New Technologies
-
Continuous Glucose Monitoring Systems in Routine Clinical Practice: Published Evidence
-
Future perspective
-
Summary
-
Clinics care points
-
Disclosure
-
Supplementary data
-
Insulin Therapy in Small Animals, Part 1: General Principles
-
Key points
-
Introduction
-
The choice of insulin depends on the specific clinical scenario
-
Pathophysiology: insulin requirements on the diabetes spectrum
-
Principles of insulin pharmacology
-
Compliance, adherence, convenience, and cost
-
Goals of therapy for the specific patient
-
Clinics care points
-
Declaration of Interests
-
Insulin Therapy in Small Animals, Part 2: Cats
-
Key points
-
Introduction
-
Pathophysiology: insulin requirements on the diabetes spectrum
-
Timing of insulin injection in conjunction with feeding
-
Glucose variability in different strategies of insulin therapy
-
Goals of therapy for the specific patient
-
Guidelines for choosing insulin formulations
-
Clinics care points
-
Disclosure
-
Insulin Therapy in Small Animals, Part 3: Dogs
-
Key points
-
Introduction
-
Insulin physiology and pathophysiology
-
Managing Inappetence and Gastrointestinal Signs
-
Goals of therapy for the specific patient
-
Formulation-specific considerations
-
KeyPoints
-
Clinics care points
-
Disclosure
-
Nutritional Management of Cats and Dogs with Diabetes Mellitus
-
Key points
-
Introduction
-
Summary
-
Declaration of Interests
-
The Future of Diabetes Therapies: New Insulins and Insulin Delivery Systems, Glucagon-Like Peptide 1 Analogs, Sodium-Glucose Cotransporter Type 2 Inhibitors, and Beta Cell Replacement Therapy
-
Key points
-
Introduction
-
Ultra-long-acting insulins
-
Glucagon-like peptide 1-based therapies
-
Sodium-glucose cotransporter type 2 inhibitors
-
Non-injectable insulins
-
Continuous insulin infusion
-
Smart insulin
-
Beta cell replacement therapy
-
Summary
-
Clinics care points
-
Disclosure
-
Hypersomatotropism and Other Causes of Insulin Resistance in Cats
-
Key points
-
Introduction
-
Lack of glucose response to insulin-true insulin resistance
-
Hypersomatotropism
-
Prevalence and cause
-
Clinical presentation
-
Characteristics of diabetes mellitus secondary to hypersomatotropism
-
Diagnosis
-
Insulin-like growth factor-1 dynamics and impact on diagnosis
-
Imaging
-
Treatment
-
Prognosis
-
Hypercortisolism
-
Prevalence and etiology
-
Clinical presentation and characteristics of diabetes mellitus secondary to hypercortisolism
-
Diagnosis
-
Imaging
-
Treatment options for hypercortisolism
-
Medical treatment (pituitary-dependent hyperadrenocorticism and adrenal-dependent hyperadrenocorticism)
-
Hypophysectomy (pituitary-dependent hyperadrenocorticism)
-
Unilateral or bilateral adrenalectomy (adrenal-dependent hyperadrenocorticism or pituitary-dependent hyperadrenocorticism)
-
Radiation therapy (pituitary-dependent hyperadrenocorticism)
-
Quality of life and prognosis
-
Clinics care points
-
Disclosure
-
Cushing’s Syndrome and Other Causes of Insulin Resistance in Dogs
-
Key points
-
Insulin resistance
-
Cushing syndrome
-
The effect of Cushing-associated dysglycemia in diabetic dogs
-
Diagnosis of canine hypercortisolism
-
Diestrus
-
Obesity
-
Summary
-
Clinics care points
-
Disclosure